[{"Assets_0_Q3_USD":1182906000.0,"CommonStockSharesOutstanding_0_Q3_shares":66693348.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-266240000.0,"NetIncomeLoss_1_Q3_USD":-76393000.0,"NetIncomeLoss_3_Q3_USD":-221023000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":66209000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":65454000.0,"StockholdersEquity_0_Q3_USD":639848000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":78486000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":216619000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181031"}]